Yonezawa, Japan

Chikako Satou



Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chikako Satou: Innovator in Cancer Cell Research

Introduction

Chikako Satou is a prominent inventor based in Yonezawa, Japan. She has made significant contributions to the field of cancer research through her innovative work. Her dedication to improving cancer treatment options has led to the development of a unique patent that enhances cancer cell adhesiveness.

Latest Patents

Chikako Satou holds a patent for an "Agent for improving cancer cell adhesiveness." This invention involves a polymer that comprises a constitutional unit represented by a specific formula. The polymer is particularly useful when applied to the surface of a cancer cell enrichment filter. By improving the adhesiveness of cancer cells to the filter surface, the enrichment ratio of the cancer cells can be significantly enhanced. The formula includes variables where R is a hydrogen atom or a methyl group, and R is a methyl group or an ethyl group, with m ranging from 1 to 3. This innovative approach has the potential to advance cancer research and treatment methodologies.

Career Highlights

Chikako Satou is associated with Hitachi Chemical Company, Ltd., where she continues to work on groundbreaking research in cancer cell technology. Her career is marked by a commitment to scientific excellence and innovation.

Collaborations

Chikako has collaborated with notable colleagues, including Hisashige Kanbara and Masaru Tanaka. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in cancer research.

Conclusion

Chikako Satou's contributions to cancer research through her innovative patent demonstrate her commitment to improving medical technology. Her work not only enhances the understanding of cancer cell behavior but also paves the way for future advancements in treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…